Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 | MMWR

Posted on March 4, 2022 by weehingthong

https://t.co/baKVonJ6u6
— simonthong aka kitty poo (@KittyPo80176717) March 4, 2022

This entry was posted in Uncategorized and tagged Covid Pfizer vaccine for 5-17. Bookmark the permalink.